พบ "Public health policy"ทั้งหมด 1,196 ผลลัพธ์
เรียงลำดับตาม
ฮ - ก

Report: Technical Workshop on Infectious Disease Modelling

Infectious disease models can be used to forecast future outbreaks and estimate the impact of interventions to support policy. Although infectious disease modelling is a well-established method, it has recently gained prominence during the COVID-19 pandemic as an important tool to support deci

Report: Precision Medicine Reference Case Workshop in Thailand

Executive summary The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing the potential of PM, signa

Report: Global Outbreak Alert and Response Network (GOARN) Regional Partners Meeting

The Global Outbreak Alert and Response Network (GOARN) is a network of more than 250 technical institutions and networks globally that respond to acute public health events with the deployment of staff and resources to affected countries, coordinated by World Health Organization (WHO). Health Interv

Relationship between socioeconomic, demographic, health and social characteristics and ability to access reliable information on herbal and food supplements: analysis of Thai Health Literacy Survey 2019

Abstract Background: The consumption of herbal and food supplements attributing to health expenditures in Thailand has been increasing over the years. However, information on herbal and food supplement products can make it difficult for some people with limited health literacy to use. Evidence fr

Reducing sedentary behaviour and physical inactivity in the workplace: protocol for a review of systematic reviews

Abstract Background and objective Increasing rates of urbanisation have been accompanied by higher levels of sedentary behaviour (SB) and reduced physical activity (PA) worldwide. While physical inactivity has long been identified as a major risk factor for morbidity and mortality, increased c

Rare diseases – Talk of the Town for Some Time but What’s Next?

Because of their rarity, rare diseases are often treated with what the industry refers to as ‘orphan drugs’. These group of drugs are quite expensive because of the fewer number of people suffering from such sickness and usually provide low profit to manufacturer compared to other common drug for n

Rapid H.I.V. Home Test Wins Federal Approval

After decades of controversy, the Food and Drug Administration approved a new H.I.V. test on Tuesday that for the first time makes it possible for Americans to learn in the privacy of their homes whether they are infected.The availability of an H.I.V. test as easy to use as a home-pregnancy kit is y
10 / หน้า